New York, Sept. 08, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Commercial Biotechnology Separation Systems Industry” – https://www.reportlinker.com/p03646062/?utm_source=GNW
5 Billion in the year 2020, is projected to reach a revised size of US$31 Billion by 2027, growing at a CAGR of 3.4% over the analysis period 2020-2027. DNA Microarray, one of the segments analyzed in the report, is projected to record a 6.5% CAGR and reach US$7.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Liquid Chromatography segment is readjusted to a revised 2.4% CAGR for the next 7-year period.3M CompanyAB SciexAgilent Technologies, Inc.Alfa Laval ABAlfa Wassermann Separation Technologies LLCBeckman Coulter Inc.Becton Dickinson and CompanyBio-Rad Laboratories Inc.Flottweg SEFluidigm CorporationGE HealthcareHitachi High-Technologies Corp.Illumina Inc.Merck KGaAPall CorporationPerkinElmer Inc.ProMetic Life Sciences Inc.Repligen CorporationSartorius Stedim Biotech SAShimadzu Scientific InstrumentsSysmex Partec GmbHThermo Fischer Scientific Inc.Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
Source
